期刊文献+

慢性阻塞性肺疾病急性加重期102例的临床治疗观察 被引量:1

Clinical Study of 102 Cases of Acute Exacerbation of Chronic Obstructive Pulmonary Disease
暂未订购
导出
摘要 目的:观察在综合治疗基础上,全身或局部使用糖皮质激素对慢性阻塞性肺疾病急性加重期的临床疗效。方法:慢性阻塞性肺疾病急性加重期患者102例,随机分为对照组和治疗1、2组。对照组给予氧疗、抗感染、止咳、祛痰、纠正酸碱平衡等;治疗组在上述治疗基础上加用静脉滴注甲基强的松龙吸入布地奈德粉吸入剂或二丙酸倍氯米松,组间进行疗效观察。结果:甲基强的松龙治疗组和吸入布地奈德混悬液或二丙酸倍氯米松治疗组与对照组比较疗效差异具有显著性,疗效明显;两个治疗组比较,差异无显著性,疗效相同。结论:慢性阻塞性肺疾病急性加重期早期使用糖皮质激素可以缩短恢复时间,加快肺功能改善并降低治疗失败率。 Objectives:To observe the clinical effect of glucocorticostteroid on acute exacerbation of chronic obstructive pulmonary disease based on comprehensive treatment. Methods: One hundred and two cases of acute exacerbation of chronic obstructive pulmonary disease were randomly divided into treatment group 1 & 2 ( n1 = 38, n2 = 34) and control group ( n = 30) .The control group was given antibiotics, oxygen and treatment for expectoration, relieved cough and balanced hydro-elctrolytic. The treatment group was given the therapies mentioned above and methylprednisolone 80mg once a day for 3 days, prednisone 30mg once a day for 10 days, budesonide 400μg twice a day or beclometasone 200μg once every 8 hours. Results: The significant difference was seen between the treatment group and the control group( P 〈 0.05 ). The significant difference was not found among the two treatment groups. Conclusions: Gglucocorticostteroid is effective for acute excerbation of chronic obstructive pulmonary disease.
作者 邱勤
机构地区 四川省建筑医院
出处 《四川省卫生管理干部学院学报》 2005年第4期250-251,共2页 Journal of Sichuan Continuing Education College of Medical Sciences
关键词 肺疾病 慢性阻塞性 急性加重 糖皮质激素 疗效 Pulmonary disease Chronic obstructive Acute exacerbation Glucocorticostteroid Effect
  • 相关文献

参考文献3

二级参考文献31

  • 1Barnes PJ, Pedersen S and Busse WW. Eflicaey and safety of inhaled corticosteroids ( new development). Am J Respir Cdt Care Med,1998, 157: 1-53.
  • 2Fein A. Management of acute exacerbations in chronic obstructive pulmonary disease. Curt Opin Pulm Med, 2000, 6: 122-126.
  • 3Burge S, Wedzicha JA. COPD exacerbations: definitions and classifications. Eur Respir J Supp1,2003,41:46s-53s.
  • 4Seemunsal TA, Donaldson GC f Bhowmik A, et al. Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med,2000,161 : 1608-1613.
  • 5Buhl R, Farmer SG. Current and future pharmacologic therapy of exacerbations in chronic obstructive pulmonary disease and asthma.Proc Am Thorac Soc.2004.1:136-142.
  • 6Anthonisen NR, Manfreda J, Warren CP, et al. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Intern Med, 1987,106 : 196-204.
  • 7Rodriguez-Roisin R. Toward a consensus definition for COPD exacerbations. Chest,2000,117(5 Suppl 2) :398SM01S.
  • 8Snow V, Lascher S, Mottur-Pilson C, et al.Evidence base for management of acute exacerbations of chronic obstructive pulmonary disease. Ann Intern Med ,2001,134.595-599.
  • 9Panwels RA, Buist AS, Calverley PM, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J ResDir Crlt Care Med ,2001,163:1256-1276.
  • 10Celli BR, MacNee W. ATS/ERS Task Force. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J ,2004,23:932-946.

共引文献5157

同被引文献7

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部